| 95% CrI | Probability that Etoricoxib 30 mg Shows Small, Moderate or Large Improvement Relative to Comparator* | |||||
|---|---|---|---|---|---|---|
| Comparator (mg) | ES** | Low | High | Small | Moderate | Large |
| acetaminophen 4000 | -0.57 | -0.79 | -0.35 | 1.00 | 0.74 | 0.02 |
| nsNSAIDs | ||||||
| naproxen 1000 | -0.24 | -0.45 | -0.04 | 0.66 | 0.01 | 0.00 |
| ibuprofen 2400 | -0.20 | -0.47 | 0.07 | 0.50 | 0.02 | 0.00 |
| diclofenac 150 | -0.09 | -0.33 | 0.14 | 0.18 | 0.00 | 0.00 |
| COX-2 selective NSAIDs | ||||||
| celecoxib 100 | -0.46 | -0.72 | -0.21 | 0.98 | 0.39 | 0.01 |
| celecoxib 200 | -0.27 | -0.43 | -0.10 | 0.79 | 0.00 | 0.00 |
| celecoxib 400 | -0.35 | -0.58 | -0.13 | 0.91 | 0.10 | 0.00 |
| lumiracoxib 100 | -0.29 | -0.52 | -0.07 | 0.80 | 0.03 | 0.00 |
| lumiracoxib 200 | -0.26 | -0.49 | -0.04 | 0.71 | 0.02 | 0.00 |
| lumiracoxib 400 | -0.25 | -0.47 | -0.02 | 0.66 | 0.01 | 0.00 |